View More View Less
  • 1 Department of Microbiology of Clinical Center of Serbia Belgrade Serbia
  • | 2 Clinic for Infectious and Tropical Diseases of Clinical Center of Serbia Belgrade Serbia
  • | 3 Henry Ford Hospital Detroit MI USA
  • | 4 Wayne State University School of Medicine Detroit MI USA
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The purpose of this study was to evaluate the molecular relatedness of clinical isolates of vancomycin-resistant enterococci (VRE) collected from patients of the Clinic for Infectious and Tropical Diseases in Belgrade. Among 40 isolates available for the investigation, 36 were identified as Enterococcus faecium, whereas 2 were Enterococcus faecalis and Enterococcus raffinosus, respectively. Pulsed-field gel electrophoresis (PFGE) typing revealed 21 strain types, comprising 7 clusters which contained at least two isolates and 14 unique PFGE patterns. Although we searched for pathogenicity factor genes (gelE, cylB, asa1, efaAfs, esp, cpd, cob) in representatives of all macro-restriction patterns, they have been confirmed in only one clone of E. faecalis. Genes esp and hyl, commonly found in E. faecium, were yilded in 10 macro-restriction patterns of this species, and their presence could not be ascribed to clonally related strains (p = 0.05). All VRE isolates were multiresistant and positive for vanA gene. Twenty strains of VRE and 6 clusters obtained from Intensive care unit (ICU) are proof of intensive transmission of these microorganisms at this department. The results of this study suggest wide genotypic variability among the clinical VRE isolates, but also intrahospital dissemination of some of them.

  • Linden, P.K., Miller, C.B.: Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen. Diagn Micr Infect Dis 33, 113–120 (1999).

    Miller C.B. , 'Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen ' (1999 ) 33 Diagn Micr Infect Dis : 113 -120.

    • Search Google Scholar
  • Hidron, A., Edwards, J.R., Patel, J., Horan, T.C., Sievert, D.M., Pollock, D.A., Fridkin, S.K; National Healthcare Safety Network Team; Participating National Healthcare Safety Net-work Facilities: NHSN annual update: Antimicrobial resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29, 996–1011 (2008).

    Fridkin S.K. , 'National Healthcare Safety Network Team; Participating National Healthcare Safety Net-work Facilities: NHSN annual update: Antimicrobial resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 ' (2008 ) 29 Infect Control Hosp Epidemiol : 996 -1011.

    • Search Google Scholar
  • LeClercq, R., Deriot, E., Duval, J., Courvalin, P.: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319, 157–161.

  • Uttley, A.H.C., Collins, C.H., Naidoo, J., George, R.C.: Vancomycin-resistant enterococci. Lancet 1, 57–58 (1988).

    George R.C. , 'Vancomycin-resistant enterococci ' (1988 ) 1 Lancet : 57 -58.

  • Schouten, M.A., Hoogkamp-Korstanje, J.A., Meis, J.F., Voss, A.: Prevalence of vanco-mycin-resistant enterococci in Europe. Eur J ClinMicrobiol Infect Dis 19, 816–822 (2000).

    Voss A. , 'Prevalence of vanco-mycin-resistant enterococci in Europe ' (2000 ) 19 Eur J ClinMicrobiol Infect Dis : 816 -822.

    • Search Google Scholar
  • The European Antimicrobial Resistance Surveillance System. EARSS Results. [Database on the internet.] http://www.ecdc.europa.eu/en/ activities/surveillance/EARS-Net/Pages/Database.aspx

  • Fournier, S., Brossier, F., Fortineau, N., Gillaizeau, F., Akpabie, A., Aubry, A., Barbut, F., Chedhomme, F.X., Kassis-Chikhani, N., Lucet, J.C., Robert, J., Seytre, D., Simon, I., Vanjak, D., Zahar, J.R., Brun-Buisson, C., Jarlier, V.: Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: A seven-year experience. Euro Surveill 26, 17(30) (2012).

    '' (2012 ) 26 Euro Surveill : -.

  • Hegstad, K., Mikalsen, T., Coque, T.M., Werner, G., Sundsfjord, A.: Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin Microbiol Infect 16, 541–554 (2010).

    Sundsfjord A. , 'Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium ' (2010 ) 16 Clin Microbiol Infect : 541 -554.

    • Search Google Scholar
  • Coque, T.M., Tomayko, J.F., Ricke, S.C., Okhyusen, P.C., Murray, B.E.: Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 40, 2605–2609 (1996).

    Murray B.E. , 'Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States ' (1996 ) 40 Antimicrob Agents Chemother : 2605 -2609.

    • Search Google Scholar
  • Stošović, B., Stepanović, S., Donabedian, S., Tošić, T., Jovanović, M.: First case of vanco-mycin-resistant Enterococcus faecalis in Serbia. Emerg Infect Dis 10, 158–159 (2004).

    Jovanović M. , 'First case of vanco-mycin-resistant Enterococcus faecalis in Serbia ' (2004 ) 10 Emerg Infect Dis : 158 -159.

    • Search Google Scholar
  • Libisch, B., Lepsanovic, Z., Top, J., Muzslay, M., Konkoly-Thege, M., Gacs, M., Balogh, B., Fuzi, M., Willems, R.: Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia. Scand J Infect Dis 40, 778–784 (2008).

    Willems R. , 'Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia ' (2008 ) 40 Scand J Infect Dis : 778 -784.

    • Search Google Scholar
  • Facklam, R.R., Sahm, D.F., Teixeira, L.M.: Enterococcus. In: Murray, P. (ed.), Manual of Clinical Microbiology. Washington, D.C.: ASM Press, 1999, pp. 297–305.

    Teixeira L.M. , '', in Manual of Clinical Microbiology , (1999 ) -.

  • Clinical and Laboratory Standards Institute (2007): Performance standards for anti-microbial susceptibility testing; Seventeenth Informational Supplement M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA, USA.

    '', in Performance standards for anti-microbial susceptibility testing; Seventeenth Informational Supplement M100-S16 , (2007 ) -.

  • Donabedian, S., Chow, J.W., Shlaes, D.M., Green, M., Zervos, M.J.: DNA probes and con-tour-clamped homogenous field electrophoresis for identification of enterococci to the species level. J Clin Microbiol 33, 141–145 (1995).

    Zervos M.J. , 'DNA probes and con-tour-clamped homogenous field electrophoresis for identification of enterococci to the species level ' (1995 ) 33 J Clin Microbiol : 141 -145.

    • Search Google Scholar
  • Tenover, F.C., Arbeit, R., Goering, R.V., Mickelsen, P.A., Murray, B., Persing, D.H., Swaminathan, B.: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 33, 2233–2239 (1995).

    Swaminathan B. , 'Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing ' (1995 ) 33 J Clin Microbiol : 2233 -2239.

    • Search Google Scholar
  • Dutka-Malen, S., Evers, S., Courvalin, P.: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33, 24–27 (1995).

    Courvalin P. , 'Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR ' (1995 ) 33 J Clin Microbiol : 24 -27.

    • Search Google Scholar
  • Eaton, T.J., Gasson, M.J.: Molecular screening of enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Env Microbiol 67, 1628–1635 (2001).

    Gasson M.J. , 'Molecular screening of enterococcus virulence determinants and potential for genetic exchange between food and medical isolates ' (2001 ) 67 Appl Env Microbiol : 1628 -1635.

    • Search Google Scholar
  • Vankerckhoven, V., Van Autgaerden, T., Vael, C., Chapelle, S., Rossi, R., Jabes, D., Goosens, H.: Development of a multiplex PCR for the detection of asa1, gel e, cyl A, esp, and hyl genes in Enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 42, 4473–4479 (2004).

    Goosens H. , 'Development of a multiplex PCR for the detection of asa1, gel e, cyl A, esp, and hyl genes in Enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. ' (2004 ) 42 J Clin Microbiol : 4473 -4479.

    • Search Google Scholar
  • Sofaniou, D., Pournaras, S., Giosi, M., Polyzou, A., Maniatis, A.N., Tsakris, A.: Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. J Antimicrob Chemother 54, 251–254 (2004).

    Tsakris A. , 'Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval ' (2004 ) 54 J Antimicrob Chemother : 251 -254.

    • Search Google Scholar
  • Montecalvo, M.A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F.C., Issah, A., Cook, P., Wormser, G.P.: Outbreak of vancomycin, ampicillin, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 38, 1363–1367 (1994).

    Wormser G.P. , 'Outbreak of vancomycin, ampicillin, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit ' (1994 ) 38 Antimicrob Agents Chemother : 1363 -1367.

    • Search Google Scholar
  • Oprea, S., Zaidi, N., Donabedian, S., Balasubramaniam, M., Hershberger, E., Zervos, M.: Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis. J Antimicrob Chemother 53, 626–630 (2004).

    Zervos M. , 'Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis ' (2004 ) 53 J Antimicrob Chemother : 626 -630.

    • Search Google Scholar
  • Maniatis, A.N., Pournaras, S., Kanellopoulou, M., Kontos, F., Dimitroulia, E., Parafangas, E., Tsakris, A.: Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital. J Clin Microbiol 39, 4571–4574 (2001).

    Tsakris A. , 'Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital ' (2001 ) 39 J Clin Microbiol : 4571 -4574.

    • Search Google Scholar
  • Calfee, D.P.: Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Grampositives in healthcare. Curr Opin Infect Dis 25, 385–394 (2012).

    Calfee D.P. , 'Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Grampositives in healthcare ' (2012 ) 25 Curr Opin Infect Dis : 385 -394.

    • Search Google Scholar
  • Leavis, H.L., Willems, R.J.L., Top, J., Spalburg, E., Mascini, E.M., Fluit, A.C., Hoepelman, A., de Neeling, A.J., Bonten, M.J.: Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg Infect Dis 9, 1108–1115 (2003).

    Bonten M.J. , 'Epidemic and nonepidemic multidrug-resistant Enterococcus faecium ' (2003 ) 9 Emerg Infect Dis : 1108 -1115.

    • Search Google Scholar
  • Willems, R.J., Homan, W., Top, J., van Santen-Verheuvel, M., Tribe, D., Manzioros, X., Gaillard, C., Vandenbroucke-Grauls, C.M., Mascini, E.M., van Kregten, E., van Embden, J.D., Bonten, M.J.: Variant esp gene as a marker of a distinct genetic lineage of vanco-mycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357, 853–855 (2001).

    Bonten M.J. , 'Variant esp gene as a marker of a distinct genetic lineage of vanco-mycin-resistant Enterococcus faecium spreading in hospitals ' (2001 ) 357 Lancet : 853 -855.

    • Search Google Scholar
  • Woodford, N., Soltani, M., Hardy, K.J.: Frequency of esp in Enterococcus faecium isolates. Lancet 358, 584 (2001).

    Hardy K.J. , 'Frequency of esp in Enterococcus faecium isolates ' (2001 ) 358 Lancet : 584 -.

  • Goossens, H.: Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Infect Control Hosp Epidemiol 19, 546–551 (1998).

    Goossens H. , 'Spread of vancomycin-resistant enterococci: differences between the United States and Europe ' (1998 ) 19 Infect Control Hosp Epidemiol : 546 -551.

    • Search Google Scholar
  • Falk, P.S., Winnike, J., Woodmansee, C., Desai, M., Mayhal, C.G.: Outbreak of vanco-mycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 21, 575–582 (2000).

    Mayhal C.G. , 'Outbreak of vanco-mycin-resistant enterococci in a burn unit ' (2000 ) 21 Infect Control Hosp Epidemiol : 575 -582.

    • Search Google Scholar
  • Hsueh, P.R., Teng, L.J., Pan, H.J., Chen, Y.C., Wang, L.H., Chang, S.C., Ho, S.W., Luh, K.T.: Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: Persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol 20, 828–833 (1999).

    Luh K.T. , 'Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: Persistence of multiple species and multiple clones ' (1999 ) 20 Infect Control Hosp Epidemiol : 828 -833.

    • Search Google Scholar
  • Donskey, C.J., Hoyen, C.K., Das, S.M., Helfand, M.S., Hecker, M.T.: Recurrence of vanco-mycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 23, 436–440 (2002).

    Hecker M.T. , 'Recurrence of vanco-mycin-resistant Enterococcus stool colonization during antibiotic therapy ' (2002 ) 23 Infect Control Hosp Epidemiol : 436 -440.

    • Search Google Scholar
  • Juh, J.Y., Lee, W.G., Jin, H.Y.: Molecular characterization of vancomycin-resistant enterococci from clinical and surveillance specimens. Infect Control Hosp Epidemiol 27, 1076–1080 (2006).

    Jin H.Y. , 'Molecular characterization of vancomycin-resistant enterococci from clinical and surveillance specimens ' (2006 ) 27 Infect Control Hosp Epidemiol : 1076 -1080.

    • Search Google Scholar
  • Dutka-Malen, S., Blaimont, B., Wauters, G., Courvalin, P.: Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother 38, 1675–1677 (1994).

    Courvalin P. , 'Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus ' (1994 ) 38 Antimicrob Agents Chemother : 1675 -1677.

    • Search Google Scholar
  • Kawalec, M., Gniadkowski, M., Hryniewicz, W.: Outbreak of vancomycin-resistant enterococci in a hospital in Gdask, Poland, due to horizontal transfer of different Tn1546- like transposon variants and clonal spread of several strains. J Clin Microbiol 38, 3317–3322 (2000).

    Hryniewicz W. , 'Outbreak of vancomycin-resistant enterococci in a hospital in Gdask, Poland, due to horizontal transfer of different Tn1546- like transposon variants and clonal spread of several strains ' (2000 ) 38 J Clin Microbiol : 3317 -3322.

    • Search Google Scholar
  • Novais, C., Coque, T., Ferreira, H., Sousa, J.K., Peixe, L.: Molecular characterization of glycopeptide-resistant Enterococcus faecium isolates from Portuguese hospitals. Antimicrob Agents Chemother 49, 3073–3079 (2005).

    Peixe L. , 'Molecular characterization of glycopeptide-resistant Enterococcus faecium isolates from Portuguese hospitals ' (2005 ) 49 Antimicrob Agents Chemother : 3073 -3079.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 3 0 0
Feb 2021 4 0 0
Mar 2021 4 0 0
Apr 2021 2 0 0
May 2021 5 0 0
Jun 2021 0 0 0
Jul 2021 0 0 0